- 专利标题： GLUCAGON ANALOG AND MEDICAL USE THEREOF
-
申请号： EP22824309.3申请日： 2022-06-17
-
公开(公告)号： EP4357358A1公开(公告)日： 2024-04-24
- 发明人: LIU, Weibing , HUANG, Xuchao , ZHANG, Xiaoqian , WU, Fangzhou , WANG, Lei , QU, Liang
- 申请人： Beijing Tuo Jie Biopharmaceutical Co. Ltd.
- 申请人地址： CN Beijing 102206 Level 7, No.4 Building, No.9 Yi Ke Road ZGC Life Science Park Changping District
- 专利权人： Beijing Tuo Jie Biopharmaceutical Co. Ltd.
- 当前专利权人： Beijing Tuo Jie Biopharmaceutical Co. Ltd.
- 当前专利权人地址： CN Beijing 102206 Level 7, No.4 Building, No.9 Yi Ke Road ZGC Life Science Park Changping District
- 代理机构： Dragotti & Associati S.R.L.
- 优先权： CN 202110676681 2021.06.18
- 国际申请： CN2022099357 2022.06.17
- 国际公布： WO2022262837 2022.12.22
- 主分类号： C07K14/605
- IPC分类号： C07K14/605 ; A61K38/26 ; A61P3/10
摘要：
A glucagon analog and the medical use thereof. Specifically, the glucagon analog has a significantly improved in vitro activity, excellent physical/chemical stability, and high solubility, and can be used to treat metabolic diseases such as hypoglycemia, obesity, and diabetes.
信息查询
